SOAT1 and non-small cell lung carcinoma: Combining the Jak inhibitor and cisplatin enhances the growth of cisplatin-inhibition-resistant NSCLC and induces apoptosis, highlighting that the JAK-STAT signaling pathway is crucial to the combination of FTY720 and cisplatin [19,38].